A test kit determines the presence of coronavirus in patient samples by converting and amplifying viral RNA to DNA targeting the spike protein gene of the 2019 nCov virus With copyspace for

High-Value
Laboratory Diagnostics

Ultrasens™ PCR Kits

Ultrasens™ panels are multiplexed assays for real-time polymerase chain reaction (qPCR) designed to detect pathogens and antibiotic resistance genes. These panels facilitate fast analysis of a broad spectrum of infections in a cost-effective and scalable format, delivering results in less than two hours. 

Comprehensive portfolio of multiplexed polymerase-chain-reaction panels for laboratories with integrated TreatOnce™ reports to enable laboratories to deliver highervalue service to their customers. 

Features

  • Ease-of-use—convenient, duplexed reactions include assay and positive control 
  • Turn-around time—predefined panels with a short turn-around time 
  • Pre-spotted and dried down on 96-well plates designed for easy setup  
  • Controls— RNase P human internal control per well 
  • Maximize the workflow includes all necessary reagents for the reaction, ensuring a comprehensive and efficient testing process 

Ultrasens™ kits are manufactured in the United States for research use only. Not for use in diagnostic procedures. 

TreatOnce™

TreatOnce™ clinical decision support software complements Ultrasens™ molecular assays by mapping targeted antibiotic treatment options based on the detected pathogens and antimicrobial resistance genes. Recommendations can be printed in a clear, printable report.